Dauntless Investment Group’s Armata Pharmaceuticals ARMP Stock Holding History
Bought
Maintained
Sold
Other funds holding ARMP
GWM
Dauntless Investment Group's ARMP Position: Q3 2026 in Review
Dauntless Investment Group reduced its Armata Pharmaceuticals (ARMP) stake by 96% in Q3 2026, selling an estimated $929K and leaving 9,105 shares worth $33.4K. The position accounts for 0.03% of the portfolio, ranked #45.
Dauntless Investment Group first reported a position in ARMP in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.32M in Q2 2026. 64 funds tracked by Wall St. Rank hold ARMP as of Q3 2026.
- Dauntless Investment Group held 9,105 shares of Armata Pharmaceuticals worth $33.4K as of Q3 2026.
- Dauntless Investment Group sold 194,786 Armata Pharmaceuticals shares in Q3 2026, an estimated $929K.
- Armata Pharmaceuticals made up 0.03% of Dauntless Investment Group's portfolio in Q3 2026, its #45 holding.
- Dauntless Investment Group first reported a position in Armata Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
- Dauntless Investment Group's Armata Pharmaceuticals position peaked at $1.32M in Q2 2026.
- 64 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q3 2026.
Based on Dauntless Investment Group's 13F filing for Q3 2026, filed 16 Nov 2026.